Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.24, 2026.8.4
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
It plans to complete the world's first medium-sized high-temperature stellarator by 2027.
We invite you to revisit the July "highlight reel."
Recently, **NewPro Bioworks (Shanghai Xinyicui Biotechnology Co., Ltd.) announced the completion of a Pre-A funding round worth tens of millions of RMB**. This round was jointly led by **SSCI Leading Fund and Aochuang Pioneer Fund — the latter established by Dalton Venture in partnership with listed industry player OPM Biosciences, making it the first bio-manufacturing industry CVC fund in the Yangtze River Delta region**. Meanwhile, the company's self-developed precision-fermented lactoferrin product
Counselor Vitality
MiniMax H3 is taking the next step: abandoning the old architecture and building a new tokenizer.
On August 3, **Shanghai Initiative Technology Co., Ltd. (hereinafter referred to as "Initiative Technology") announced the completion of a 330 million RMB angel funding round, setting a new record for angel-round financing in China's brain-computer interface sector. This round was led by CASSTAR, with co-investment from Dalton Venture, Legend Star, Unity Ventures, Inno Angel Fund, BGI Songhe Bio Fund, LYFE Capital, and Jiadao Capital**. The proceeds will be mainly used for facility expansion, equipment upgrades, and clinical trial advancement.
From "Can Move" to "Can Get Things Done"
The domestic invasive brain-computer interface company with the most comprehensive product line
"Saving the model through a detour" — a pun on 曲线救国 ("saving the nation through a detour," a historical euphemism for indirect approaches), applied to AI model development or distribution strategies that work around direct obstacles (regulatory, technical, or competitive).